Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal Antibody, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01241552
What this trial is testing

MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)

Who this might be right for
Clostridium Difficile Infection
Merck Sharp & Dohme LLC 1,452
Early research (Phase 1)Study completedNCT00816400
What this trial is testing

A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors.

Who this might be right for
Cancer
MedImmune LLC 49
Testing effectiveness (Phase 2)Study completedNCT05400655
What this trial is testing

Anti-malaria MAb in Kenyan Children

Who this might be right for
Plasmodium Falciparum InfectionMalaria
National Institute of Allergy and Infectious Diseases (NIAID) 912
Early research (Phase 1)Active Not RecruitingNCT05378425
What this trial is testing

NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+2 more
Nectin Therapeutics Ltd 90
Early research (Phase 1)Study completedNCT01514123
What this trial is testing

Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors

Who this might be right for
NeoplasmsCancer
Circadian Technologies Ltd. 43
Very early researchNot Yet RecruitingNCT07213882
What this trial is testing

A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL)

Who this might be right for
Cutaneous T Cell Lymphoma (CTCL)Mycosis FungoidesSezary Syndrome
Assistance Publique - Hôpitaux de Paris 30
Large-scale testing (Phase 3)Ended earlyNCT04649515
What this trial is testing

Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans

Who this might be right for
Coronavirus Disease-2019 (COVID-19)
Tychan Pte Ltd. 17
Large-scale testing (Phase 3)Study completedNCT00573794
What this trial is testing

Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie (prior sponsor, Abbott) 592
Testing effectiveness (Phase 2)Study completedNCT01160666
What this trial is testing

Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
Assistance Publique - Hôpitaux de Paris 20
Early research (Phase 1)Study completedNCT02463227
What this trial is testing

Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody (VRC01) in HIV-Infected Adults Undergoing a Brief Treatment Interruption

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 14
Testing effectiveness (Phase 2)Study completedNCT00001061
What this trial is testing

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 167
Early research (Phase 1)Study completedNCT01005355
What this trial is testing

Study of IMC-1121B in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 15
Early research (Phase 1)Study completedNCT03364348
What this trial is testing

4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer

Who this might be right for
HER2 Positive Breast CarcinomaRecurrent Breast CarcinomaStage III Breast Cancer+4 more
George W. Sledge Jr. 18
Early research (Phase 1)Study completedNCT03588650
What this trial is testing

HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai Henlius Biotech 26
Testing effectiveness (Phase 2)Study completedNCT07060508
What this trial is testing

L9LS in Women of Childbearing Potential in Mali

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 279
Testing effectiveness (Phase 2)WithdrawnNCT01479179
What this trial is testing

Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT03443830
What this trial is testing

Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans

Who this might be right for
Treatment of Acute Zika Virus Infection
Tychan Pte Ltd. 24
Early research (Phase 1)Looking for participantsNCT07238075
What this trial is testing

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
Advanced MalignancyAdvanced Solid CancersMetastatic Solid Tumors
Adcytherix SAS 290
Large-scale testing (Phase 3)Study completedNCT03298867
What this trial is testing

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study

Who this might be right for
Thyroid Eye DiseaseGraves' Orbitopathy
Amgen 83
Testing effectiveness (Phase 2)Study completedNCT02694822
What this trial is testing

AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy

Who this might be right for
Advanced Solid CancersAdvanced Solid Cancers Refractory to PD-1 and PD-L1 Therapies
Agenus Inc. 89
Next Page